Healthcare Policy Briefing - Dec 15 - Dec 21, 2025

Dec 15 - Dec 21, 2025

34 articles analyzed

Executive Summary

This week's healthcare landscape is defined by a federal-state power struggle over medical debt and AI regulation, alongside a significant crackdown on health data 'rent-extraction' by federal technology officials. Meanwhile, new clinical data suggests digital musculoskeletal programs are achieving meaningful reductions in surgical volumes, providing a clear ROI path for value-based care strategies.

Key Takeaways

HHS/ASTP has effectively banned revenue-sharing fees for electronic health information (EHI) access that exceed cost recovery, forcing EHR vendors toward usage-based pricing models. Source
Digital musculoskeletal (MSK) programs reduce surgical risk by 58% and low-value surgery by 82%, offering payers a validated alternative to high-cost orthopedic interventions. Source
The CFPB's reversal on state authority to regulate credit reports is forcing state lawmakers to shift from credit reporting bans to interest rate caps and wage garnishment protections. Source
The potential expiration of ACA premium subsidies is driving consumers toward high-deductible plans, which may lead to decreased adherence to chronic care treatments. Source

Key Themes

Major trends and developments identified from this week's coverage

Data Monetization Reform

Federal regulators are moving to eliminate platform overreach in health data exchange, shifting the industry from revenue-sharing models to cost-recovery frameworks.

Federal-State Regulatory Friction

Conflicting federal and state policies are creating operational uncertainty in areas ranging from AI oversight to medical debt collection.

Proven Digital Outcomes

Digital-first care models are beginning to produce large-scale evidence of cost avoidance and surgical redirection.

Regulatory & Policy Updates

CMS/MEDICARE

RCE Delays Mandatory Reciprocity for Payment and Operations (P&O)

Delayed enforcement aims to lower adoption barriers for TEFCA, allowing organizations more time to align operational workflows with nationwide exchange requirements.

FDA

FDA Leadership Proposes Shift to Large Placebo-Controlled Vaccine Trials

Moving away from surrogate immune markers could significantly increase the cost and duration of vaccine development, potentially making several pediatric pipelines economically unviable.

LEGISLATIVE

HHS Issues RFI on Accelerating AI Adoption in Clinical Care

Input gathered will likely shape future reimbursement codes and regulatory guardrails for clinical decision support tools.

Technology & Innovation

Digital MSK Programs Reduce Surgery Incidence by 58%

Payers and self-insured employers should prioritize digital physical therapy as a primary diversion strategy for musculoskeletal spend.

Philosophical Critique Warns AI Scribes May Mechanize Clinical Care

Health systems must balance the efficiency gains of AI scribes against the risk of reducing physician roles to purely procedural or 'calculative' functions.

Market & Competitive Intelligence

Genesis HealthCare

M&A

A federal judge blocked a reorganization plan for Genesis HealthCare, once the largest US nursing home chain, prevents investors from shielding themselves from $1.6B in liability claims.

Fondazione Telethon

Partnership

Fondazione Telethon successfully launched a gene therapy for Wiskott-Aldrich syndrome using a non-profit model for treatments abandoned by commercial developers.

Japan Biotech Sector

Market Entry

Japan is implementing a strategic initiative to upgrade its biotech ecosystem and compete more aggressively in global drug development.

What to Watch

HTI-5 Rule Finalization

Q1-Q2 2025

ASTP is expected to finalize rules that will de-certify legacy EHR criteria in favor of API-first standards, lowering switching costs for providers.

Genesis HealthCare Bankruptcy Auction

January 2024 (scheduled)

A new auction for Genesis HealthCare assets will proceed without liability shields, setting a precedent for nursing home investor accountability.

State vs Federal AI Regulation Battle

Ongoing through 2025

A federal moratorium on state-level AI regulation is being contested by advocates of 'laboratories of democracy,' which could lead to a fragmented regulatory landscape.

Want personalized briefings?

Kelp creates AI-powered briefings tailored to your specific interests and sources. Get the insights that matter most to you.

Start Your Free Briefing